Glendon E. French III
President and CEO at Pulmonx Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Pulmonx Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Pulmonx Corporation May 17, 202455.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Pulmonx Corporation | Open-market sale | −4,098 | $2.26 | $9,261 |
| Sep 1, 2026 | Pulmonx Corporation | Open-market sale | −37,784 | $2.26 | $85,392 |
| Jun 2, 2026 | Pulmonx Corporation | Open-market sale | −13,511 | $1.57 | $21,212 |
| Jun 1, 2026 | Pulmonx Corporation | Open-market sale | −4,171 | $1.54 | $6,423 |
| Jun 1, 2026 | Pulmonx Corporation | Open-market sale | −38,467 | $1.54 | $59,239 |
| Mar 2, 2026 | Pulmonx Corporation | Open-market sale | −2,708 | $1.43 | $3,872 |
| Mar 2, 2026 | Pulmonx Corporation | Open-market sale | −6,737 | $1.43 | $9,634 |
| Mar 2, 2026 | Pulmonx Corporation | Open-market sale | −58,368 | $1.43 | $83,466 |
| Dec 1, 2025 | Pulmonx Corporation | Open-market sale | −2,524 | $1.57 | $3,963 |
| Dec 1, 2025 | Pulmonx Corporation | Open-market sale | −6,281 | $1.57 | $9,861 |
| Dec 1, 2025 | Pulmonx Corporation | Grant or award | +1,200,000 | — | — |
| Jun 2, 2025 | Pulmonx Corporation | Grant or award | +37,153 | — | — |
| Mar 20, 2025 | Pulmonx Corporation | Open-market sale | −20,000 | $7.85 | $157,000 |
| Feb 20, 2025 | Pulmonx Corporation | Open-market sale | −43,036 | $8.14 | $350,313 |
| Feb 20, 2025 | Pulmonx Corporation | Open-market sale | −12,417 | $8.76 | $108,773 |
Questions about Glendon E. French III
What boards is Glendon E. French III on?
Glendon E. French III sits on the boards of Edap TMS S.A. and Pulmonx Corporation.
Has Glendon E. French III been a CEO?
Yes — Glendon E. French III was CEO of Pulmonx Corporation (Until March 2024).
How long has Glendon E. French III served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.